Strs Ohio lowered its stake in shares of Atrion Corporation (NASDAQ:ATRI) by 13.3% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,300 shares of the medical instruments supplier’s stock after selling 200 shares during the period. Strs Ohio owned about 0.07% of Atrion Corporation worth $873,000 as of its most recent SEC filing.
Several other large investors also recently modified their holdings of the business. State Street Corp boosted its stake in shares of Atrion Corporation by 3.0% during the 2nd quarter. State Street Corp now owns 31,790 shares of the medical instruments supplier’s stock valued at $20,446,000 after buying an additional 919 shares during the period. Janus Henderson Group PLC acquired a new stake in shares of Atrion Corporation during the 2nd quarter valued at $13,898,000. Hillsdale Investment Management Inc. acquired a new stake in shares of Atrion Corporation during the 2nd quarter valued at $708,000. Voya Investment Management LLC boosted its stake in shares of Atrion Corporation by 10.2% during the 2nd quarter. Voya Investment Management LLC now owns 755 shares of the medical instruments supplier’s stock valued at $486,000 after buying an additional 70 shares during the period. Finally, OxFORD Asset Management LLP acquired a new stake in shares of Atrion Corporation during the 2nd quarter valued at $1,080,000. 59.62% of the stock is owned by institutional investors.
In related news, Chairman Emile A. Battat sold 1,408 shares of Atrion Corporation stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $652.91, for a total value of $919,297.28. Following the completion of the sale, the chairman now owns 148,881 shares of the company’s stock, valued at approximately $97,205,893.71. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 23.10% of the stock is currently owned by insiders.
Separately, BidaskClub lowered shares of Atrion Corporation from a “strong-buy” rating to a “buy” rating in a research note on Thursday, July 27th.
Shares of Atrion Corporation (NASDAQ ATRI) opened at $662.00 on Friday. The stock has a market cap of $1,225.89, a price-to-earnings ratio of 39.78 and a beta of 0.86. Atrion Corporation has a 52 week low of $433.95 and a 52 week high of $694.00.
Atrion Corporation (NASDAQ:ATRI) last released its quarterly earnings data on Tuesday, August 8th. The medical instruments supplier reported $5.40 earnings per share (EPS) for the quarter. Atrion Corporation had a net margin of 22.75% and a return on equity of 18.67%. The business had revenue of $36.16 million during the quarter.
COPYRIGHT VIOLATION WARNING: “Strs Ohio Decreases Holdings in Atrion Corporation (ATRI)” was first reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this story on another site, it was illegally copied and reposted in violation of United States & international copyright and trademark laws. The original version of this story can be accessed at https://sportsperspectives.com/2017/11/05/strs-ohio-decreases-holdings-in-atrion-corporation-atri.html.
About Atrion Corporation
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company’s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety.
Want to see what other hedge funds are holding ATRI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Atrion Corporation (NASDAQ:ATRI).
Receive News & Ratings for Atrion Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Atrion Corporation and related companies with MarketBeat.com's FREE daily email newsletter.